Biggest News Aggregation in the World
📰 Consensus Clinical News

Consensus Clinical News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Consensus Clinical. Real-time updates on events, politics, business and more.

Acadia Pharmaceuticals Initiates Phase 2 Clinical Trial of ACP-204 for the Treatment of Alzheimer's Disease Psychosis -November 27, 2023 at 09:08 am EST

Acadia Pharmaceuticals Inc. today announced the initiation of a Phase 2 study evaluating the efficacy and safety of ACP-204 for the treatment of hallucinations and delusions associated with...
United States Alzheimers Dement Acadia Pharmaceuticals Research Definition Acadia Pharmaceuticals Inc Alzheimer Association

Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer's Disease Psychosis

Acadia Pharmaceuticals Announces August 4, 2022 Action Date for Resubmitted Supplemental New Drug Application for NUPLAZID® (pimavanserin) for the Treatment of Alzheimer’s Disease Psychosis - read this article along with other careers information, tips and advice on BioSpace
United States Steve Davis Alzheimers Dement Drug Administration Advisory Committee International Psychogeriatric Associations

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science